Definium Therapeutics DFTX Cash Flow Statement (2020-2026)

NASDAQ DFTX
$35.09 +2.12 (+6.43%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Definium Therapeutics Quarterly Cash Flow Statement

Periods 23 quarters
Latest Jun 2026

Definium Therapeutics reported cash from operations of -$52.78M and free cash flow of -$52.78M for the quarter ended Jun 2026, down 78.3% year over year. This cash flow statement covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-17.20M-16.83M-18.45M-16.96M-16.49M-4.90M-24.82M-29.13M-17.92M-23.86M-54.40M-5.85M-13.68M-34.74M-23.35M-42.74M-67.27M-50.44M-77.10M-158.99M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.80M0.79M0.80M0.80M0.80M0.80M0.80M0.80M0.80M0.80M0.53M
Amortization of Deferred ChargesAmort. Deferred Charges
0.04M0.04M
Share-based CompensationStock Comp.
4.11M4.34M3.79M4.25M4.29M1.38M3.75M3.84M4.23M3.37M3.69M5.43M3.84M3.95M3.43M5.25M5.82M5.60M7.13M9.64M
Other non-cash itemsOther Non-Cash
0.01M-7.98M5.20M1.50M-3.02M2.53M33.48M-15.99M-8.36M5.41M-7.02M2.23M22.55M5.27M20.27M86.23M
Change in Working Capital
Change in Account PayablesChange Payables
0.69M0.65M-0.84M-2.59M0.10M1.27M0.21M6.26M-0.93M-3.51M1.51M-2.96M-0.53M-0.14M0.26M1.95M3.90M-2.77M1.78M-0.16M
Change in Accured ExpensesChange Accured Exp.
-5.47M7.52M0.99M-0.20M-0.17M-1.04M0.70M3.19M-0.15M1.58M-2.70M0.99M1.03M3.79M-1.33M3.01M3.36M0.92M2.99M6.85M
Change in Other Operating AssetsOther Assets Change
-0.87M3.09M-0.92M0.38M-1.30M2.28M-0.93M-0.13M-0.58M1.55M-0.53M1.46M-0.51M3.87M1.39M-3.13M-0.87M2.42M-0.70M0.40M
Other Working Capital ChangesOther WC Changes
0.87M-3.09M0.92M-0.38M1.30M-2.28M0.93M0.13M0.58M-1.55M0.53M-1.46M0.51M-3.87M-1.39M3.13M0.87M-2.42M0.70M-0.40M
Cash from OperationsCash from Ops.
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.33M-13.85M-16.63M-20.56M-16.60M-19.99M-17.19M-25.35M-29.42M-29.60M-29.57M-42.98M-42.63M-52.78M
Investing Activities
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
162.46M73.29M26.59M6.02M355.74M
Sale and Maturity of InvestmentsInvestments Sold
33.75M42.00M41.00M42.00M39.00M
Other Investing ActivitiesOther investing
-0.03M
Cash from Investing ActivitiesCash from Investing
-0.03M0.11M-162.46M-39.54M15.41M34.98M42.00M-316.74M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.82M0.13M0.24M0.59M59.40M0.73M0.58M1.27M-1.74M7.58M2.17M3.89M0.03M253.88M1.00M0.10M0.75M261.81M5.31M808.68M
Net Shares Issued and RepurchasedNet Shares Issued
0.82M0.13M0.24M0.59M59.40M0.73M0.58M1.27M-1.74M7.58M2.17M3.89M0.03M253.88M1.00M0.10M0.75M261.81M5.31M808.68M
Net Equity Issued and RepurchasedNet Equity Issued
0.82M0.13M0.24M0.59M59.40M0.73M0.58M1.27M-1.74M7.58M2.17M3.89M0.03M253.88M1.00M0.10M0.75M261.81M5.31M808.68M
Other financing activitiesOther financing
-0.41M-0.04M-8.90M-2.09M-5.28M-0.45M-15.95M
Cash from Financing ActivitiesCash from Financing
0.82M0.13M-0.17M0.59M58.21M0.42M0.58M1.27M17.40M2.59M169.25M10.79M69.35M3.81M1.00M19.65M0.75M245.87M5.31M762.27M
Additional items
Exchange Rate EffectFX Effect
4.81M-4.79M-0.04M-0.19M-0.14M0.06M0.02M0.06M0.03M-0.03M-0.02M0.00M-0.01M0.00M-0.01M0.03M-0.02M0.00M0.00M0.00M
Change in Cash
-11.18M-12.38M-13.07M-14.73M48.78M-12.38M-12.73M-12.51M0.80M-18.00M152.63M-9.20M52.15M-21.54M-190.89M-49.46M-13.43M237.88M4.68M392.75M
Ending Cash Balance
145.92M133.54M120.47M105.74M154.52M142.14M129.41M116.90M117.70M99.70M252.33M243.13M295.28M273.74M82.85M33.39M19.96M257.84M262.52M655.27M
Free Cash FlowFCF
-16.78M-7.83M-12.87M-15.13M-9.30M-12.85M-13.33M-13.85M-16.63M-20.56M-16.60M-19.99M-17.19M-25.35M-29.42M-29.60M-29.57M-42.98M-42.63M-52.78M
Net Cash FlowNCF
-15.99M-7.59M-13.03M-14.54M48.91M-12.43M-12.75M-12.57M0.77M-17.97M152.65M-9.20M52.16M-21.54M-190.88M-49.49M-13.41M237.88M4.68M392.75M
Interest Paid
0.43M0.43M0.44M0.67M0.68M0.60M2.59M1.46M0.69M1.05M1.07M

Definium Therapeutics Cash Flow Statement API

Pull Definium Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DFTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY